Sanoptis

Sanoptis is an innovative European ophthalmology services group, covering the full spectrum of diagnostic and surgical ophthalmic treatments. The group partners with leading ophthalmologists to deliver on the organic and inorganic growth opportunities within the market.

Volker Wendel

Co-Founder and CEO

2 past transactions

Retinai

Series B in 2024
RetinAI optimises and simplifies clinics, research and pharmaceutical workflows to improve healthcare. To achieve this goal, the company builds tools to collect, analyze and organize health data, empowering healthcare professionals and patients with automatic image and data analysis supported by advanced machine learning. RetinAI has proprietary technology that provides unforeseen image quality enhancement, as well as automatic analysis of medical data for hospitals, private practitioners, pharmaceutical companies and device manufacturers at similar level of performance as a human would produce.

AugenAllianz-Zentren

Acquisition in 2019
AugenAllianz-Zentren is full spectrum of diagnostic and surgical ophthalmic treatments.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.